Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protagonist Therapeutics (PTGX) Interest Expenses (2020)

Historic Interest Expenses for Protagonist Therapeutics (PTGX) over the last 1 years, with Q4 2020 value amounting to $127000.0.

  • Protagonist Therapeutics' Interest Expenses changed N/A to $127000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $127000.0, marking a year-over-year decrease of 7303.61%. This contributed to the annual value of $598000.0 for FY2020, which is 25384.62% up from last year.
  • According to the latest figures from Q4 2020, Protagonist Therapeutics' Interest Expenses is $127000.0.
  • Protagonist Therapeutics' Interest Expenses' 5-year high stood at $243000.0 during Q1 2020, with a 5-year trough of $19000.0 in Q3 2020.